Global Anti-Viral Drugs Market Growth 2025-2031
The global Anti-Viral Drugs market size is predicted to grow from US$ 127250 million in 2025 to US$ 157610 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Viral Drugs Industry Forecast? looks at past sales and reviews total world Anti-Viral Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Viral Drugs sales for 2025 through 2031. With Anti-Viral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Viral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-Viral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Viral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Viral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Viral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Viral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Viral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Viral Drugs market?
What factors are driving Anti-Viral Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Viral Drugs market opportunities vary by end market size?
How does Anti-Viral Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Viral Drugs Industry Forecast? looks at past sales and reviews total world Anti-Viral Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Viral Drugs sales for 2025 through 2031. With Anti-Viral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Viral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-Viral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Viral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Viral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Viral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Viral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Viral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Nucleotide Polymerase Inhibitor
- Reverse Transcriptase Inhibitor
- Protease Inhibitor
- HIV
- Hepatitis
- HSV
- Influenza
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Bristol-Myers-Squibb
- AbbVie
- Johnson & Johnson
- Merck & Co
- Aurobindo Pharma
- Cipla
- Dr Reddy?s
What is the 10-year outlook for the global Anti-Viral Drugs market?
What factors are driving Anti-Viral Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Viral Drugs market opportunities vary by end market size?
How does Anti-Viral Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Viral Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Viral Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Viral Drugs by Country/Region, 2020, 2024 & 2031
2.2 Anti-Viral Drugs Segment by Type
2.2.1 Nucleotide Polymerase Inhibitor
2.2.2 Reverse Transcriptase Inhibitor
2.2.3 Protease Inhibitor
2.3 Anti-Viral Drugs Sales by Type
2.3.1 Global Anti-Viral Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Viral Drugs Sale Price by Type (2020-2025)
2.4 Anti-Viral Drugs Segment by Application
2.4.1 HIV
2.4.2 Hepatitis
2.4.3 HSV
2.4.4 Influenza
2.5 Anti-Viral Drugs Sales by Application
2.5.1 Global Anti-Viral Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Viral Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Viral Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Viral Drugs Breakdown Data by Company
3.1.1 Global Anti-Viral Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Viral Drugs Sales Market Share by Company (2020-2025)
3.2 Global Anti-Viral Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Viral Drugs Revenue by Company (2020-2025)
3.2.2 Global Anti-Viral Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Viral Drugs Sale Price by Company
3.4 Key Manufacturers Anti-Viral Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Viral Drugs Product Location Distribution
3.4.2 Players Anti-Viral Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-VIRAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-Viral Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Viral Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Viral Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Viral Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Viral Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Viral Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Viral Drugs Sales Growth
4.4 APAC Anti-Viral Drugs Sales Growth
4.5 Europe Anti-Viral Drugs Sales Growth
4.6 Middle East & Africa Anti-Viral Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-Viral Drugs Sales by Country
5.1.1 Americas Anti-Viral Drugs Sales by Country (2020-2025)
5.1.2 Americas Anti-Viral Drugs Revenue by Country (2020-2025)
5.2 Americas Anti-Viral Drugs Sales by Type (2020-2025)
5.3 Americas Anti-Viral Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Viral Drugs Sales by Region
6.1.1 APAC Anti-Viral Drugs Sales by Region (2020-2025)
6.1.2 APAC Anti-Viral Drugs Revenue by Region (2020-2025)
6.2 APAC Anti-Viral Drugs Sales by Type (2020-2025)
6.3 APAC Anti-Viral Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Viral Drugs by Country
7.1.1 Europe Anti-Viral Drugs Sales by Country (2020-2025)
7.1.2 Europe Anti-Viral Drugs Revenue by Country (2020-2025)
7.2 Europe Anti-Viral Drugs Sales by Type (2020-2025)
7.3 Europe Anti-Viral Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Viral Drugs by Country
8.1.1 Middle East & Africa Anti-Viral Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Viral Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Viral Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Viral Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Viral Drugs
10.3 Manufacturing Process Analysis of Anti-Viral Drugs
10.4 Industry Chain Structure of Anti-Viral Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Viral Drugs Distributors
11.3 Anti-Viral Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-VIRAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-Viral Drugs Market Size Forecast by Region
12.1.1 Global Anti-Viral Drugs Forecast by Region (2026-2031)
12.1.2 Global Anti-Viral Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Viral Drugs Forecast by Type (2026-2031)
12.7 Global Anti-Viral Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Anti-Viral Drugs Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bristol-Myers-Squibb
13.3.1 Bristol-Myers-Squibb Company Information
13.3.2 Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bristol-Myers-Squibb Main Business Overview
13.3.5 Bristol-Myers-Squibb Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Anti-Viral Drugs Product Portfolios and Specifications
13.4.3 AbbVie Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Anti-Viral Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co
13.6.1 Merck & Co Company Information
13.6.2 Merck & Co Anti-Viral Drugs Product Portfolios and Specifications
13.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck & Co Main Business Overview
13.6.5 Merck & Co Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Anti-Viral Drugs Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Cipla
13.8.1 Cipla Company Information
13.8.2 Cipla Anti-Viral Drugs Product Portfolios and Specifications
13.8.3 Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cipla Main Business Overview
13.8.5 Cipla Latest Developments
13.9 Dr Reddy?s
13.9.1 Dr Reddy?s Company Information
13.9.2 Dr Reddy?s Anti-Viral Drugs Product Portfolios and Specifications
13.9.3 Dr Reddy?s Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Dr Reddy?s Main Business Overview
13.9.5 Dr Reddy?s Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Viral Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Viral Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Viral Drugs by Country/Region, 2020, 2024 & 2031
2.2 Anti-Viral Drugs Segment by Type
2.2.1 Nucleotide Polymerase Inhibitor
2.2.2 Reverse Transcriptase Inhibitor
2.2.3 Protease Inhibitor
2.3 Anti-Viral Drugs Sales by Type
2.3.1 Global Anti-Viral Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Viral Drugs Sale Price by Type (2020-2025)
2.4 Anti-Viral Drugs Segment by Application
2.4.1 HIV
2.4.2 Hepatitis
2.4.3 HSV
2.4.4 Influenza
2.5 Anti-Viral Drugs Sales by Application
2.5.1 Global Anti-Viral Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Viral Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Viral Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Viral Drugs Breakdown Data by Company
3.1.1 Global Anti-Viral Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Viral Drugs Sales Market Share by Company (2020-2025)
3.2 Global Anti-Viral Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Viral Drugs Revenue by Company (2020-2025)
3.2.2 Global Anti-Viral Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Viral Drugs Sale Price by Company
3.4 Key Manufacturers Anti-Viral Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Viral Drugs Product Location Distribution
3.4.2 Players Anti-Viral Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-VIRAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-Viral Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Viral Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Viral Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Viral Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Viral Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Viral Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Viral Drugs Sales Growth
4.4 APAC Anti-Viral Drugs Sales Growth
4.5 Europe Anti-Viral Drugs Sales Growth
4.6 Middle East & Africa Anti-Viral Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-Viral Drugs Sales by Country
5.1.1 Americas Anti-Viral Drugs Sales by Country (2020-2025)
5.1.2 Americas Anti-Viral Drugs Revenue by Country (2020-2025)
5.2 Americas Anti-Viral Drugs Sales by Type (2020-2025)
5.3 Americas Anti-Viral Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Viral Drugs Sales by Region
6.1.1 APAC Anti-Viral Drugs Sales by Region (2020-2025)
6.1.2 APAC Anti-Viral Drugs Revenue by Region (2020-2025)
6.2 APAC Anti-Viral Drugs Sales by Type (2020-2025)
6.3 APAC Anti-Viral Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Viral Drugs by Country
7.1.1 Europe Anti-Viral Drugs Sales by Country (2020-2025)
7.1.2 Europe Anti-Viral Drugs Revenue by Country (2020-2025)
7.2 Europe Anti-Viral Drugs Sales by Type (2020-2025)
7.3 Europe Anti-Viral Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Viral Drugs by Country
8.1.1 Middle East & Africa Anti-Viral Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Viral Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Viral Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Viral Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Viral Drugs
10.3 Manufacturing Process Analysis of Anti-Viral Drugs
10.4 Industry Chain Structure of Anti-Viral Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Viral Drugs Distributors
11.3 Anti-Viral Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-VIRAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-Viral Drugs Market Size Forecast by Region
12.1.1 Global Anti-Viral Drugs Forecast by Region (2026-2031)
12.1.2 Global Anti-Viral Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Viral Drugs Forecast by Type (2026-2031)
12.7 Global Anti-Viral Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Anti-Viral Drugs Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bristol-Myers-Squibb
13.3.1 Bristol-Myers-Squibb Company Information
13.3.2 Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolios and Specifications
13.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bristol-Myers-Squibb Main Business Overview
13.3.5 Bristol-Myers-Squibb Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Anti-Viral Drugs Product Portfolios and Specifications
13.4.3 AbbVie Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Anti-Viral Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co
13.6.1 Merck & Co Company Information
13.6.2 Merck & Co Anti-Viral Drugs Product Portfolios and Specifications
13.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck & Co Main Business Overview
13.6.5 Merck & Co Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Anti-Viral Drugs Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Cipla
13.8.1 Cipla Company Information
13.8.2 Cipla Anti-Viral Drugs Product Portfolios and Specifications
13.8.3 Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cipla Main Business Overview
13.8.5 Cipla Latest Developments
13.9 Dr Reddy?s
13.9.1 Dr Reddy?s Company Information
13.9.2 Dr Reddy?s Anti-Viral Drugs Product Portfolios and Specifications
13.9.3 Dr Reddy?s Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Dr Reddy?s Main Business Overview
13.9.5 Dr Reddy?s Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Viral Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Viral Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nucleotide Polymerase Inhibitor
Table 4. Major Players of Reverse Transcriptase Inhibitor
Table 5. Major Players of Protease Inhibitor
Table 6. Global Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 7. Global Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Anti-Viral Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Anti-Viral Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Anti-Viral Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Anti-Viral Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Viral Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Viral Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Viral Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Viral Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Viral Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Viral Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Viral Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Viral Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Viral Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Viral Drugs Producing Area Distribution and Sales Area
Table 22. Players Anti-Viral Drugs Products Offered
Table 23. Anti-Viral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Viral Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Viral Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Viral Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Viral Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Viral Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Viral Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Viral Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Viral Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Viral Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Viral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 38. Americas Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Viral Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Viral Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Viral Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 43. APAC Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Viral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 47. Europe Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Viral Drugs
Table 53. Key Market Challenges & Risks of Anti-Viral Drugs
Table 54. Key Industry Trends of Anti-Viral Drugs
Table 55. Anti-Viral Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Viral Drugs Distributors List
Table 58. Anti-Viral Drugs Customer List
Table 59. Global Anti-Viral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Viral Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Viral Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Viral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Viral Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Viral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Viral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Viral Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Anti-Viral Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Anti-Viral Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Viral Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. F. Hoffmann-La Roche Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolios and Specifications
Table 75. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Main Business
Table 77. F. Hoffmann-La Roche Latest Developments
Table 78. GlaxoSmithKline Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Anti-Viral Drugs Product Portfolios and Specifications
Table 80. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Bristol-Myers-Squibb Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolios and Specifications
Table 85. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bristol-Myers-Squibb Main Business
Table 87. Bristol-Myers-Squibb Latest Developments
Table 88. AbbVie Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Anti-Viral Drugs Product Portfolios and Specifications
Table 90. AbbVie Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Johnson & Johnson Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Anti-Viral Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Merck & Co Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck & Co Anti-Viral Drugs Product Portfolios and Specifications
Table 100. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Merck & Co Main Business
Table 102. Merck & Co Latest Developments
Table 103. Aurobindo Pharma Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Anti-Viral Drugs Product Portfolios and Specifications
Table 105. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Cipla Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla Anti-Viral Drugs Product Portfolios and Specifications
Table 110. Cipla Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Dr Reddy?s Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Dr Reddy?s Anti-Viral Drugs Product Portfolios and Specifications
Table 115. Dr Reddy?s Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Dr Reddy?s Main Business
Table 117. Dr Reddy?s Latest Developments
Table 1. Anti-Viral Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Viral Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nucleotide Polymerase Inhibitor
Table 4. Major Players of Reverse Transcriptase Inhibitor
Table 5. Major Players of Protease Inhibitor
Table 6. Global Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 7. Global Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Anti-Viral Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Anti-Viral Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Anti-Viral Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Anti-Viral Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Viral Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Viral Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Viral Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Viral Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Viral Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Viral Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Viral Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Viral Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Viral Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Viral Drugs Producing Area Distribution and Sales Area
Table 22. Players Anti-Viral Drugs Products Offered
Table 23. Anti-Viral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Viral Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Viral Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Viral Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Viral Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Viral Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Viral Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Viral Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Viral Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Viral Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Viral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 38. Americas Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Viral Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Viral Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Viral Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 43. APAC Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Viral Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 47. Europe Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Viral Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Viral Drugs Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Viral Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Viral Drugs
Table 53. Key Market Challenges & Risks of Anti-Viral Drugs
Table 54. Key Industry Trends of Anti-Viral Drugs
Table 55. Anti-Viral Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Viral Drugs Distributors List
Table 58. Anti-Viral Drugs Customer List
Table 59. Global Anti-Viral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Viral Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Viral Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Viral Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Viral Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Viral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Viral Drugs Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Viral Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Viral Drugs Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Anti-Viral Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Anti-Viral Drugs Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Viral Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. F. Hoffmann-La Roche Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolios and Specifications
Table 75. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Main Business
Table 77. F. Hoffmann-La Roche Latest Developments
Table 78. GlaxoSmithKline Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Anti-Viral Drugs Product Portfolios and Specifications
Table 80. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Bristol-Myers-Squibb Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolios and Specifications
Table 85. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bristol-Myers-Squibb Main Business
Table 87. Bristol-Myers-Squibb Latest Developments
Table 88. AbbVie Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Anti-Viral Drugs Product Portfolios and Specifications
Table 90. AbbVie Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Johnson & Johnson Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Anti-Viral Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Merck & Co Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck & Co Anti-Viral Drugs Product Portfolios and Specifications
Table 100. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Merck & Co Main Business
Table 102. Merck & Co Latest Developments
Table 103. Aurobindo Pharma Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Anti-Viral Drugs Product Portfolios and Specifications
Table 105. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Cipla Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla Anti-Viral Drugs Product Portfolios and Specifications
Table 110. Cipla Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Dr Reddy?s Basic Information, Anti-Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Dr Reddy?s Anti-Viral Drugs Product Portfolios and Specifications
Table 115. Dr Reddy?s Anti-Viral Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Dr Reddy?s Main Business
Table 117. Dr Reddy?s Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Viral Drugs
Figure 2. Anti-Viral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Viral Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Viral Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Viral Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Viral Drugs Sales Market Share by Country/Region (2024)
Figure 10. Anti-Viral Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Nucleotide Polymerase Inhibitor
Figure 12. Product Picture of Reverse Transcriptase Inhibitor
Figure 13. Product Picture of Protease Inhibitor
Figure 14. Global Anti-Viral Drugs Sales Market Share by Type in 2025
Figure 15. Global Anti-Viral Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Anti-Viral Drugs Consumed in HIV
Figure 17. Global Anti-Viral Drugs Market: HIV (2020-2025) & (K Units)
Figure 18. Anti-Viral Drugs Consumed in Hepatitis
Figure 19. Global Anti-Viral Drugs Market: Hepatitis (2020-2025) & (K Units)
Figure 20. Anti-Viral Drugs Consumed in HSV
Figure 21. Global Anti-Viral Drugs Market: HSV (2020-2025) & (K Units)
Figure 22. Anti-Viral Drugs Consumed in Influenza
Figure 23. Global Anti-Viral Drugs Market: Influenza (2020-2025) & (K Units)
Figure 24. Global Anti-Viral Drugs Sale Market Share by Application (2024)
Figure 25. Global Anti-Viral Drugs Revenue Market Share by Application in 2025
Figure 26. Anti-Viral Drugs Sales by Company in 2025 (K Units)
Figure 27. Global Anti-Viral Drugs Sales Market Share by Company in 2025
Figure 28. Anti-Viral Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Anti-Viral Drugs Revenue Market Share by Company in 2025
Figure 30. Global Anti-Viral Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Anti-Viral Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 33. Americas Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 35. APAC Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 37. Europe Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Anti-Viral Drugs Sales Market Share by Country in 2025
Figure 41. Americas Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Anti-Viral Drugs Sales Market Share by Region in 2025
Figure 49. APAC Anti-Viral Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Anti-Viral Drugs Sales Market Share by Country in 2025
Figure 60. Europe Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Anti-Viral Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-Viral Drugs in 2025
Figure 77. Manufacturing Process Analysis of Anti-Viral Drugs
Figure 78. Industry Chain Structure of Anti-Viral Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-Viral Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Anti-Viral Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Anti-Viral Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Anti-Viral Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-Viral Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Anti-Viral Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Anti-Viral Drugs
Figure 2. Anti-Viral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Viral Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Viral Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Viral Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Viral Drugs Sales Market Share by Country/Region (2024)
Figure 10. Anti-Viral Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Nucleotide Polymerase Inhibitor
Figure 12. Product Picture of Reverse Transcriptase Inhibitor
Figure 13. Product Picture of Protease Inhibitor
Figure 14. Global Anti-Viral Drugs Sales Market Share by Type in 2025
Figure 15. Global Anti-Viral Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Anti-Viral Drugs Consumed in HIV
Figure 17. Global Anti-Viral Drugs Market: HIV (2020-2025) & (K Units)
Figure 18. Anti-Viral Drugs Consumed in Hepatitis
Figure 19. Global Anti-Viral Drugs Market: Hepatitis (2020-2025) & (K Units)
Figure 20. Anti-Viral Drugs Consumed in HSV
Figure 21. Global Anti-Viral Drugs Market: HSV (2020-2025) & (K Units)
Figure 22. Anti-Viral Drugs Consumed in Influenza
Figure 23. Global Anti-Viral Drugs Market: Influenza (2020-2025) & (K Units)
Figure 24. Global Anti-Viral Drugs Sale Market Share by Application (2024)
Figure 25. Global Anti-Viral Drugs Revenue Market Share by Application in 2025
Figure 26. Anti-Viral Drugs Sales by Company in 2025 (K Units)
Figure 27. Global Anti-Viral Drugs Sales Market Share by Company in 2025
Figure 28. Anti-Viral Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Anti-Viral Drugs Revenue Market Share by Company in 2025
Figure 30. Global Anti-Viral Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Anti-Viral Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 33. Americas Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 35. APAC Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 37. Europe Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Anti-Viral Drugs Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Anti-Viral Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Anti-Viral Drugs Sales Market Share by Country in 2025
Figure 41. Americas Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Anti-Viral Drugs Sales Market Share by Region in 2025
Figure 49. APAC Anti-Viral Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Anti-Viral Drugs Sales Market Share by Country in 2025
Figure 60. Europe Anti-Viral Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Anti-Viral Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Anti-Viral Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Anti-Viral Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Anti-Viral Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-Viral Drugs in 2025
Figure 77. Manufacturing Process Analysis of Anti-Viral Drugs
Figure 78. Industry Chain Structure of Anti-Viral Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-Viral Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Anti-Viral Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Anti-Viral Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Anti-Viral Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-Viral Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Anti-Viral Drugs Revenue Market Share Forecast by Application (2026-2031)
